CIK 0001649989
- Non-accelerated filer
- Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383982704
- Phone
- +1 609-619-3990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-15 | Syntone Ventures LLC 10% owner | Purchase | +714,286 | 1,705,438 | ||
| 2024-04-15 | Syntone Ventures LLC 10% owner | Purchase · Warrant (Right to Buy) | +1,071,429 | 1,071,429 | ||
| 2021-02-03 | Syntone Ventures LLC 10% owner | Purchase | +3,000,000 | $1.00 | $3.0M | 19,823,045 |
| 2020-07-15 | Syntone Ventures LLC 10% owner | Purchase | +823,045 | $1.22 | $1000K | 16,823,045 |
Page 1 of 1 · 4 trades